Despite its proven benefits, the implementation of AMTSL faces several barriers. These include a lack of trained healthcare providers, limited access to uterotonic drugs, and inadequate healthcare infrastructure, particularly in low-resource settings. Epidemiological research can help identify these barriers and inform strategies to address them. For example, training programs for healthcare providers and policies to ensure the availability of essential drugs are critical steps to improve the uptake of AMTSL.
